非腫瘍性疾患病理アトラス　腎

出版社： 文光堂
著者：
発行日： 2022-11-01
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830604881
電子書籍版： 2022-11-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

「検体数が少ない」「そもそもどこを見たらよいのかがわからない」「疾患が多彩で複雑」などの理由から，腎生検病理を苦手とする人は少なくない．そこで本書は，腎生検病理診断を行ううえで，まずは押さえておきたい病理所見の基本的な取り方を豊富な写真と明瞭な解説で紐解き，「臨床情報からの鑑別」について詳解することで，病理・臨床双方の所見から総合的に病態を理解できるように誌面を構成した．各論では，各執筆者が主な疾患と鑑別診断の「見るべきポイント」を丁寧に解説．腎病理を専門としない病理医や腎臓内科医必携の1冊！

目次

  • 第1部　総　論
    A．正常腎の組織所見
    　I　腎の発生
    　II　糸球体の構造
    　III　尿細管と間質
    　IV　血　管
    B．腎病理組織学の基本的所見　
    　I　糸球体の所見
    　　1　メサンギウム増殖
    　　2　管内細胞増多
    　　3　膜性増殖性病変
    　　4　半月体形成─管外増殖─
    　　5　内皮障害，係蹄基底膜の二重化
    　　6　spike形成
    　　7　足細胞（ポドサイト）の病変
    　　8　糸球体結節性病変
    　　9　糸球体硬化
    　　10　分節性硬化
    　II　尿細管・間質の所見
    　　1　間質炎症
    　　2　間質線維化
    　　3　尿細管萎縮
    　III　血管の所見
    　　1　動脈硬化
    　　2　細動脈硝子化
    　　3　血管炎
    C．腎生検診断のプロセス
    　I　腎生検検体の取扱い
    　II　特殊染色で観察するポイント
    　III　腎生検診断・観察の進め方
    D．臨床情報からの鑑別診断
    　I　ネフローゼ症候群
    　II　蛋白尿・血尿の持続
    　III　急性腎障害（AKI）
    　IV　M蛋白血症
    　V　時系列でみた移植腎病理の考え方
    　VI　家族歴を有する腎疾患

    第2部　各　論
    　主な疾患と鑑別診断
    　　1　微小変化型ネフローゼ症候群と巣状分節性糸球体硬化症
    　　2　IgA腎症とIgA血管炎
    　　3　膜性腎症
    　　4　C3腎症と膜性増殖性糸球体腎炎パターンを呈する糸球体腎炎
    　　〔COLUMN〕膜性増殖性糸球体腎炎の分類Up To Date
    　　5　単クローン性IgG沈着を伴う増殖性腎炎
    　　6　糖尿病性腎症
    　　7　アミロイドーシス
    　　〔COLUMN〕質量分析を用いたアミロイドの病型診断
    　　8　organized depositsを伴う腎疾患
    　　9　ループス腎炎・膠原病関連腎症─血管炎を除く─
    　　10　感染関連腎炎
    　　11　遺伝性腎疾患
    　　12　糸球体過剰濾過に関連した腎疾患
    　　13　ANCA関連血管炎，抗GBM病
    　　14　血栓性微小血管症（TMA）
    　　〔COLUMN〕Castleman病，TAFRO症候群，POEMS症候群
    　　15　腎硬化症
    　　16　尿細管間質性腎炎，急性尿細管壊死
    　　17　IgG4関連腎臓病
    　　〔COLUMN〕IgM陽性形質細胞浸潤を伴った尿細管間質性腎炎（IgMPC-TIN）
    　　18　造血幹細胞移植に関連した腎障害
    　　19　薬剤性腎障害
    　　〔COLUMN〕免疫チェックポイント阻害薬による腎障害
    　　〔COLUMN〕クロロキン関連腎症
    　　20　悪性リンパ腫の浸潤─血管内大細胞型B細胞リンパ腫を含む─
    　　21　移植腎─拒絶─
    　　22　移植腎─ウイルス感染─

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.7 掲載の参考文献
1) Nephron. Encyclopedia Britannica, 2019. https://www.britannica.com/science/nephron
 
2) Rehman S, et al : Embryology, Kidney, Bladder, and Ureter. StatPearls. Treasure Island (FL) : StatPearls Publishing LLC, 2021. https://www.ncbi.nlm.nih.gov/books/NBK547747/
 
3) Dressler GR : Advances in early kidney specification, development and patterning. Development 136 : 3863-3874, 2009
PubMed
4) Kriz W : Ontogenetic development of the filtration barrier. Nephron Exp Nephrol 106 : e44-50, 2007
PubMed
5) Adrian S, et al : Development of the Kidney. in Jennette JC, et al. (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015
 
6) Dziarmaga A, et al : Renal hypoplasia : lessons from Pax2. Pediatr Nephrol 21 : 26-31, 2006
 
7) Eccles MR : The role of PAX2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 12 : 712-720, 1998
PubMed
8) Sanyanusin P, et al : Genomic structure of the human PAX2 gene. Genomics 35 : 258-61, 1996
PubMed
9) Costantini F, et al : Patterning a complex organ : branching morphogenesis and nephron segmentation in kidney development. Dev Cell 18 : 698-712, 2010
PubMed
10) Grieshammer U, et al : SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 6 : 709-717, 2004
PubMed
11) Hasegawa S, et al : Recent advances in renal regeneration. F1000Res 8, 2019
PubMed
12) Song R, et al : Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol 26 : 353-364, 2011
 
13) Potter EL : Facial characteristics of infants with bilateral renal agenesis. Am J Obstet Gynecol 51 : 885-888, 1946
PubMed
14) Scholz H, et al : A role for the Wilms' tumor protein WT1 in organ development. Physiology 20 : 54-59, 2004
 
15) Ulinski T, et al : Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort. J Am Soc Nephrol 17 : 497-503, 2006
 
16) Barker DJP : The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci 359 : 1359-1366, 2004
PubMed
17) Luyckx VA, et al : Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382 : 273-283, 2013
PubMed
18) Sutherland MR, et al : Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 22 : 1365-1374, 2011
 
P.15 掲載の参考文献
1) Atherton JC : Renal blood flow, glomerular filtration and plasma clearance. Anaesth Intensive Care Med 16 : 292-296, 2015
 
2) Kumar V, et al (eds) : Robbins Pathologic Basis of Disease, 8th ed., Saunders/Elsevier Philadelphia, 2007
 
3) Mundel P, et al : Structure and function of podocytes : an update. Anat Embryol (Berl) 192 : 385-397, 1995
PubMed
4) Garg P, et al : Slit diaphragm junctional complex and regulation of the cytoskeleton. Nephron Exp Nephrol 106 : e67-72, 2007
PubMed
5) Garg P, et al : Slit diaphragm junctional complex and regulation of the cytoskeleton. Nephron Exp Nephrol 106 : e67-72, 2007
PubMed
6) Bariety J, et al : Parietal podocytes in normal human Glomeruli. J Am Soc Nephrol 17 : 2770-2780, 2006
PubMed
7) Nagata M, et al : Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis Lab Invest 80 : 869-880, 2000
PubMed
8) Huber TB, et al : The slit diaphragm : a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14 : 211-216, 2005
PubMed
9) Yu SM-W, et al : Proteinuric kidney diseases : A podocyte's slit diaphragm and cytoskeleton approach : Front Med (Lausanne) 5 : 211, 2018
 
10) 淺沼克彦ほか : 腎糸球体上皮細胞の細胞特性 I-腎糸球体上皮細胞 (ポドサイト) におけるアクチン骨格制御-. 日本腎臓学会誌 50 : 532-539, 2008
 
11) Ichimura K, et al : Three-dimensional architecture of podocytes revealed by block-face scanning electron microscopy. Sci Rep 5 : 8993, 2015
PubMed
12) 森岡哲夫 : 腎糸球体内皮細胞の細胞特性-糸球体疾患における糸球体内皮細胞の役割-. 日本腎臓学会誌 50 : 547-553, 2008
 
13) Okada H, et al : Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit Care 21 : 261, 2017
PubMed
14) 射場敏明 : グリコカリックス障害と臓器微小循環. 日本血栓止血学会誌 30 : 726-732, 2019
 
15) 岡田英志 : 敗血症における微小血管傷害の超微形態. 日本臨床麻酔学会誌 39 : 730-737, 2019
Medical*Online
16) Nakagawa Y, et al : The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant 16 (Suppl 8) : 51-57, 2002
 
17) 本田一穂 : 腎移植における抗体関連型拒絶反応の病理. 信州医学雑誌 63 : 273-280, 2015
Medical*Online
18) Sidney LE, et al : Concise review : evidence for CD34 as a common marker for diverse progenitors. Stem Cells 32 : 1380-1389, 2014
PubMed
19) Pusztaszeri MP, et al : Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54 : 385-395, 2006
PubMed
20) Fleming S, et al : Antigenic heterogeneity of renal endothelium. J Pathol 158 : 319-323, 1989
PubMed
21) Takahashi T, et al : Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature J Am Soc Nephrol 10 : 2135-2145, 1999
PubMed
22) Yamamoto I, et al : Caveolin-1 expression is a distinct feature of chronic rejection-induced transplant capillaropathy. Am J Transplant 8 : 2627-2635, 2008
PubMed
23) Niemela H, et al : Molecular identification of PAL-E, a widely used endothelical-cell marker. Blood 106 : 3405-3409, 2005
 
24) Yamamoto I, et al : Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy Am J Transplant 7 : 1954-1960, 2007
PubMed
25) 折田義正ほか : メサンギウム細胞の機能とtransmembrane signalling. 膜 (MEMBRANE) 14 : 11-20, 1989
 
26) 田中瑞子 : 解剖学的特徴と病理. 腎と透析 89, 325-329, 2020
Medical*Online
27) 姚建ほか : 糸球体メサンギウム細胞の細胞特性. 日本腎臓学会誌 50 : 554-560, 2008
 
28) 浜口欣一ほか : 所見の捉え方 : 電子顕微鏡. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス 改訂版, 東京医学社, 2017, pp63-74
 
29) 海老原功ほか : 腎糸球体基底膜の構造と機能. 膜 (MEMBRANE) 14 : 2-10, 1989
 
30) 中西浩一ほか : Alport症候群. 日本腎臓学会誌 57 : 736-742, 2015
 
31) Suh JH, et al : The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol 9 : 470-477, 2013
 
32) Schlondorff D, et al : The mesangial cell revisited : no cell is an island. J Am Soc Nephrol 20 : 1179-1187, 2009
 
P.20 掲載の参考文献
1) Kriz W, et al : A standard nomenclature for structure of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS). Anat Embryol 178 : N1-8, 1988
 
2) Kriz W, et al : Structural organization of the mammalian kidney. in Seldin DW, et al (eds) : The Kidney : Physiology and Pathophysiology, 3rd ed., Lippincottt Williams & Wilkins, Philadelphia, 2000
 
3) Hodson CJ : The renal parenchyma and its blood supply. Moseley RD Jr. et al (eds) : Curr Probl Diagn Radiol 7 : 1-32, 1978.
 
4) Nakamura Y, et al : Hypoelectrolytic isoosmotic solution for infusion prevents saline-induced ultrastuructural artifacts of renal biopsy specimens. Pathol Int 265 : 374-378, 2015
 
5) Sato Y, et al : Immunology of the ageing kidney. Nat Rev Nephrol 15 : 625-640, 2019
PubMed
P.28 掲載の参考文献
1) Bonsib SM : Renal anatomy and histology. in Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2014, pp1-66
 
2) Lemley KV, et al : Structure and function of the renal vasculature. in Tisher CC, et al (eds) : Renal Pathology : With Clinical and Functional Correlations, 2nd ed., Lippincott, Philadelphia, 1994, pp981-1026
 
3) Clapp WL, et al : Kidney. in Mills SE (ed) : Histology for Pathologists, 4th ed., Lippincott Williams & Wilkins, Philadelphia, 2012, pp892-970
 
4) Navar LG, et al : The renal circulation and glomerular filtration. in Chertow G, et al (eds) : Brenner and Rector's The Kidney, 11th ed., Elsevier, Philadelphia, 2019, pp80-114
 
5) Elkoushy MA, et al : Surgical, radiologic, and endoscopic anatomy of the kidney and ureter. in Partin AW, et al (eds) : Campbell-Walsh-Wein Urology, 12th ed., Elsevier, Philadelphia, 2020, pp1865-1876
 
6) Pawlina W, et al (eds) : Urinary system. in Histology : A Text and Atlas : With Correlated Cell and Molecular Biology, 8th ed., Wolters Kluwer, Philadelphia, 2020, pp740-783
 
7) Pawlina W, et al (eds) : Cardiovascular system. in Histology : A Text and Atlas : With Correlated Cell and Molecular Biology, 8th ed., Wolters Kluwer, Philadelphia, 2020, pp432-471
 
8) Stevens A, et al (eds) : Urinary system. in Human Histology, 3rd ed., Elsevier Mosby, Philadelphia, 2005, pp293-326
 
9) Ovalle WK, et al (eds) : Urinary system. in Netter's Essential Histology : With Correlated Histopathology, 3rd ed., Elsevier, Philadelphia, 2020, pp381-405
 
10) 菊田彰夫ほか : 腎臓の血管, リンパ管, 神経. 小川和朗ほか編 : 人体組織学 5 呼吸器・泌尿器, 朝倉書店, 東京, 1990, pp298-302
 
11) 菊田彰夫ほか : 糸球体の血管構築と輸入・輸出細動脈. 小川和朗ほか編 : 人体組織学 5 呼吸器・泌尿器, 朝倉書店, 東京, 1990, pp184-190
 
12) 田口尚 : 正常腎血管系. 重松秀一ほか監訳 : 腎疾患の病理アトラス-尿細管間質疾患と血管疾患のWHO分類-, 東京医学社, 東京, 2005, pp33-42
 
13) 城謙輔ほか : 腎臓の解剖学. ジョーシキ! 腎病理診断エッセンシャル, 南山堂, 東京, 2020, pp2-7
 
14) 片渕律子 : 血管病変. 腎生検診断Navi, 改訂第2版, メジカルビュー社, 東京, 2016, pp71-84
 
15) 西慎一 : 正常腎組織と加齢変化. 腎生検プラクティカルガイド-より深い臨床診断へのアプローチ-, 南江堂, 東京, 2013, pp34-39
 
P.34 掲載の参考文献
1) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019
 
2) Jennette JC, et al : Heptinstall's Pathology of the Kidney, 7th ed, Wolters Kluwer, Philadelphia, 2015
 
3) Elema JD, et al : The glomerular mesangium : uptake and transport of intravenously injected colloidal carbon in rats. Kidney Int 9 : 395-406, 1976
PubMed
4) Rupprecht HD, et al : Cell-matrix interactions in the glomerular mesangium. Kidney Int 49 : 1575-1582, 1996
PubMed
5) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al : The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556, 2009
 
6) 田口尚ほか : 光顕による糸球体病変の定義. 病理と臨床 29 : 1189-1195, 2011
Medical*Online
7) Morita T, et al : Mesangiolysis ; an update. Am J Kidney Dis 31 : 559-573, 1998
 
8) Weening JJ, et al : The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65 : 521-530, 2004
PubMed
9) Tanji N, et al : Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11 : 1656-1666, 2000
PubMed
10) Nasr SH, et al : Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 18 : 2032-2036, 2007
 
11) Kambham N, et al : Obesity-related glomerulopathy : an emerging epidemic. Kidney Int 59 : 1498-1509, 2001
PubMed
P.41 掲載の参考文献
1) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society : The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556, 2009
 
2) 厚生労働科学研究費補助金難治性疾患克服研究事業 進行性腎障害に関する調査研究班報告IgA腎症分科会 : IgA腎症診療指針-第3版-. 日腎会誌 53 : 123-135, 2011
 
3) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 病変の定義と糸球体の傷害パターン. 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp20-29
 
4) Colvin RB, et al : Introduction to renal pathology. in Diagnostic Pathology : Kidney Diseases, 3rd ed., Elsevier, Philadelphia, 2019, pp4-24
 
5) Zhou XJ, et al : Algorithmic approach to the interpretation of renal biopsy. in Zhou XJ, et al (eds) : Silva's Diagnostic Renal Pathology, 2nd ed., Cambridge University Press, Cambridge, 2017, pp69-91
 
6) Fogo AB, et al : Normal growth and maturation. in Diagnostic Atlas of Renal Pathology, 3rd ed., Elsevier, Philadelphia, 2017, pp2-11
 
7) Jennette JC, et al : Primer on the pathologic classification and diagnosis of kidney disease. in Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp91-118
 
8) Churg J, et al : Classification of glomerular diseases. in Renal Disease : Classification and Atlas of Glomerular Disease, 2nd ed., Igaku-Shoin Medical Pub, Tokyo, 1995, pp3-21
 
9) 城謙輔 : 所見の捉え方 : 光学顕微鏡. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス 改訂版, 東京医学社, 2017, pp44-52
 
10) Trimarchi H, et al : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 91 : 1014-1021, 2017
 
P.50 掲載の参考文献
1) Jannette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp301-339
 
2) Nakagawa N, et al : Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan : A retrospective analysis of data from the Japan Renal Biopsy Registry. PLoS One 16 : e0257397, 2021
PubMed
3) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 2019, 金原出版, p28
 
4) Sethi S, et al : Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 366 : 1119-1131, 2012
 
5) Pickering MC, et al : C3 glomerulopathy : consensus report. Kidney Int 84 : 1079-1089, 2013
PubMed
6) Jefferson JA, et al : Podocyte biology for the bedside. Am J Kidney Dis 58 : 835-845, 2011
PubMed
7) Sethi S, et al : Membranoproliferative glomerulonephritis : pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31 : 341-348, 2011
PubMed
8) Smith RJH, at al : C3 glomerulopathy-understanding a rare complement-driven renal disease. Nat Rev Nephrol 15 : 129-143, 2019
 
9) Nasr SH, et al : DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep 8 : 56-64, 2017
 
10) Iatropoulos P, et al : Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies/immune complex-mediated membranoproliferative GN. J Am Soc Nephrol 29 : 283-294, 2018
PubMed
P.56 掲載の参考文献
1) Rogers TE, et al : Glomerular disease associated with nephritic syndrome and/or rapidly progressive glomerulonephritis. in Zhou XJ, et al (eds) : Silva's Diagnostic Renal Pathology, Cambridge University Press, Cambridge, 2009, pp211-228
 
2) Jennette JC : Rapidly progressive crescentic glomerulonephritis. Kidney Int 63 : 1164-1177, 2003
PubMed
3) Bajema IM, et al : Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis : classification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93 : 789-796, 2018
PubMed
4) Working Group of the international IgA Nephropathy Network and the Renal Pathology Society : The Oxford classification of IgA neohropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556, 2009
 
5) Trimarchi H, et al : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 91 : 1014-1021, 2017
 
6) 岡林佑典ほか : 糸球体腎炎の病理像と疾患分類-増殖性炎症による病理像の多様性と疾患分類-. 日腎会誌 58 : 622-631, 2016
 
7) Anguiano L, et al : The glomerular crescent : triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens 29 : 302-309, 2020
PubMed
P.61 掲載の参考文献
1) 香美祥二ほか : 非典型溶血性尿毒症症候群 (aHUS) 診療ガイド 2015. 日腎会誌 58 : 62-75, 2016
 
2) 北村博司 : 血栓性微笑血管症thrombotic microangiopathyの最近の進歩. 病理と臨床 34 : 1304-1312, 2016
 
3) 山崎善夫 : 腎血管内皮細胞障害の超微形態的評価. 天理医学紀要 19 : 114-121, 2016
Medical*Online
4) Johnson RJ : What mediates progressive glomerulosclerosis? The glomerular endothelium comes of age. Am J Pathol 151 : 1179-1181, 1997
PubMed
P.67 掲載の参考文献
1) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 膜性腎症. 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp56-59
 
2) Colvin RB, et al : Etiologies of membranous glomerulonephritis. in Diagnostic Pathology Kidney Disease, 3rd ed., Elsevier, Amsterdam, 2019, pp90-101
 
3) Markowitz GS, et al : Membranous glomerulonephritis. in Jannette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp255-300
 
4) Ehrenreich T, et al : Pathology of membranous nephropathy. in Sommers SC (ed) : Pathology Annual No.3, Appleton-Century-Crofts, New York, 1968, pp145-186
 
5) Burkholder PM, et al : Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence, and electron microscopic study. Lab Invest 23 : 459-479, 1970
PubMed
6) 本田一穂 : 膜性増殖性糸球体腎炎の病理 : 過去・現在・未来. 日腎会誌 58 : 683-647, 2016
 
7) Joh K, et al : Proposal of podocytic infolding glomerulopathy as a new disease entity. Clin Exp Nephrol 12 : 417-418, 2008
PubMed
8) Yoshimoto K, et al : Pathologic findings of initial biopsies reflect the outcome of membranous nephropathy. Kidney Int 65 : 148-153, 2004
PubMed
P.73 掲載の参考文献
1) Ichimura K, et al : Morphological processes of foot process effacement in puromycin aminonucleoside nephrosis revealed by FIB/SEM tomography. J Am Soc Nephrol 30 : 96-108, 2019
 
2) Lasagni L, et al : Podocyte mitosis-a catastrophe. Curr Mol Med 13 : 13-23, 2013
PubMed
3) Puelles VG, et al : mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans. JCI Insight 19 : e99271, 2019
 
4) Minakawa A, et al : Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy. Sci Rep 18485, 2019
PubMed
5) Kriz W, et al : A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 26 : 258-269, 2015
PubMed
6) Nagata M : Podocyte injury and its consequences, Kidney Int 89 : 1221-1230, 2016
PubMed
7) Liapis H, et al : New insights into the pathology of podocyte loss : mitotic catastrophe. Am J Pathol 183 : 1364-1374, 2013
 
8) Smeets B, et al : Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Am J Pathol 184 : 3239-3248, 2014
PubMed
P.79 掲載の参考文献
1) 日本腎病理協会/日本腎臓学会 腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, p21
 
2) Tervaert TW, et al : Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21 : 556-563, 2010
 
3) 和田隆志ほか監, 佐藤博ほか編 : 糖尿病性腎症と高血圧性腎硬化症の病理診断の手引き, 東京医学社, 2015
 
4) 和田隆志ほか編 糖尿病性腎症病期分類に基づいた腎病理診断の手引き, 東京医学社, 2019
 
5) Hu C, et al : Insights into the mechanisms involved in the expression and regulation of extracellular matrix proteins in diabetic nephropathy. Curr Med Chem 22 : 2858-2870, 2015
PubMed
6) Salvatore SP, et al : Smoking-related glomerulopathy : expanding the morphologic spectrum. Am J Nephrol 41 : 66-72, 2015
PubMed
7) Nasr SH, et al : Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol 18 : 2032-2036, 2007
 
8) Bender S, et al : Immunoglobulin light-chain toxicity in a mouse model of monoclonal immunoglobulin light-chain deposition disease. Blood 136 : 1645-1656, 2020
 
9) Zhu L, et al : Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta. Am J Pathol 147 : 375-385, 1995
PubMed
10) Sen S, et al : A proposed histopathologic classification, scoring, and grading system for renal amyloidosis : standardization of renal amyloid biopsy report. Arch Pathol Lab Med 134 : 532-544, 2010
PubMed
11) Hasegawa M, et al : Nintedanib-induced glomerular microangiopathy : a case report. CEN Case Rep 9 : 295-300, 2020
PubMed
12) Sawada A, et al : Glomerular Neovascularization in Nondiabetic Renal Allograft Is Associated with Calcineurin Inhibitor Toxicity. Nephron 144 : 37-42, 2020
PubMed
P.87 掲載の参考文献
1) Marcantoni C, et al : A perspective on arterionephrosclerosis : from pathology to potential pathogenesis. J Nephrol 20 : 518-524, 2007
PubMed
2) Manus JFA, et al : Ischemic obsolescence of renal glomeruli. The natural history of the lesions and their relation to hypertension. Lab Invest 9 : 413-434, 1960
 
3) Hill GS : Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 17 : 266-270, 2008
PubMed
4) Bohle A, et al : The compensated and the decompensated form of benign nephrosclerosis. Pathol Res Pract 174 : 357-367, 1982
PubMed
5) Kriz W, et al : A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 26 : 258-269, 2015
PubMed
6) Kriz W : Maintenance and breakdown of glomerular tuft architecture. J Am Soc Nephrol 29 : 1075-1077, 2018
PubMed
7) Jourde-Chiche N, et al : Endothelium structure and function in kidney health and disease. Nat Rev Nephrol 15 : 87-108, 2019
PubMed
8) Sethi S, et al : A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int 91 : 787-789, 2017
 
9) Moura MC, et al : Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody associated vasculitis. Nephrol Dial Transplant 2021 Aug 26 ; gfab250
 
10) Hommos MS, et al : Global glomerulosclerosis with nephrotic syndrome ; the clinical importance of age adjustment. Kidney Int 93 : 1175-1182, 2018.
PubMed
11) Chung CS, et al : Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patient with IgA nephropathy. Sci Rep 10 : 6270. 2020
PubMed
12) Kaplan C, et al : Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80 : 227-234, 1975
PubMed
13) Smith SM, et al : Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113 : 1253-1255, 1989
PubMed
14) Kremers WK, et al : Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy : the aging kidney anatomy study. Nephrol Dial Transplant 30 : 2034-2039, 2015
PubMed
P.94 掲載の参考文献
1) Rich AR : A hitherto underscribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopins Hop 100 : 173-186, 1957
 
2) Vinnet D, et al : Focal segmental glomerulosclerosis. in Jennet JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp207-254
 
3) 日本腎病理協会・日本腎臓学会腎病理標準化委員会編 : 3. 病変の定義と糸球体の傷害パターン. 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp20-29
 
4) 重松秀一 : 3-9 巣状糸球体硬化症の発生と進展の謎. 腎臓は体の鏡, 信教印刷, 2005, pp315-324
 
5) Kriz W, et al : Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J Am Soc Nephrol 12 : 496-506, 2001
PubMed
6) 重松秀一, 小林豊 : メサンギウム増生性腎炎及び硬化性腎炎. 病理と臨床 2 : 927-935, 1984
 
7) Nagata M, et al : Focal segmental glomerulosclerosis ; why does it occur sementally? Pflugers Arch 469 : 983-988, 2017
PubMed
8) Morita T, et al : Mesangiolysis : an update. J Kidney Dis 31 : 559-573, 1998
 
9) Otani M, et al : Postinflammatory glomerular recanalization is established under the accommodation of transformed mesangial cells. J Neprhol 19 : 449-457, 2006
 
10) 田口尚 : 血管病変 腎硬化症. 日本腎臓学会・腎病理診断標準化委員会・日本腎病理協会編 : 腎生検病理アトラス, 東京医学社, 2005, pp209-212
 
P.101 掲載の参考文献
1) Xu H, et al : Clinicopathological analysis of renal inflammatory pseudotumors presenting as the unilateral solitary masses. Int J Clin Exp Pathol 10 : 7734-7742, 2017.
PubMed
2) Arora K, et al : The histologocal diagnosis of IgG4-related disease on small biopsies : challenges and pitfalls. Histopathology 74 : 688-698, 2019,
 
3) Vincent KKT, et al : Renal parenchymal malakoplakia : a rare cause of ARF with a review of recent literature. Am J Kidney Dis 41 : E21. 1-E21.5, 2003
 
4) Loupy A, et al : The Banff 2019 Kidney Meetings Report (I) : Updates on and clarification of criteria for T-cell and antibody-mediated rejection. Am J Transplnt 20 : 2293-2631, 2020
 
5) Kobayashi A, et al : Medullary ray injury in renal allograft. Patol Int 60 : 744-749, 2010
 
6) Hashimoto J, et al : Clinicopathological analysis of medullary ray injury in 1-year protocol paediatric renal allograft biopsies. Nephron Clin Pract 144 (Suppl 1) : 79-85, 2021
 
7) Praga M, et al : Acute interstitial nephritis. Kidney Int 77 : 956-961, 2010
PubMed
8) Takahashi N, et al. : Tubulointerstitial nephritis with IgM-positive plasma cells. J Am Soc Nephrol 2017, 28 : 3688-3698
 
P.105 掲載の参考文献
1) 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017
 
2) XJJ Zhou, et al : Silva's Diagnostic Renal Pathology, 2nd ed, Cambridge University Press, Cambridge, 2017
 
3) Yamaguchi Y, et al : Characteristic tubulointerstitial nephritis in IgG4-related disease. Human Pathol 43 : 536-549, 2012
PubMed
4) Racusen LC, et al : The Banff 97 working classification of renal allograft pathology. Kidney Int 55 : 713-723, 1999
PubMed
5) 城謙輔ほか : ジョーシキ! 腎病理診断エッセンシャル, 南山堂, 2020
 
6) Kobayashi A, et al : Medullary ray injury in renal allografts. Pathology Int 60 : 744-749, 2010.
PubMed
7) Hashimoto J, et al : Clinicopathological analysis of medullary ray injury in 1-year protocol paediatric renal allograft biopsies. Nephron 144 (Suppl 1) : 79-85, 2020
 
8) Nangaku M : Chronic hypoxia and tubulointerstitial injury : a final common pathway to end-stage renal failure. J Am Soc Nephrol 17 : 17-25, 2006
PubMed
9) Trimarchi H, et al : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 91 : 1014-1021, 2017.
 
10) 湯村和子編 : IgA腎症の臨床, 東京医学社, 2018
 
11) 佐藤博ほか : 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き. 日本腎臓学会誌 57 : 649-725, 2015
 
P.110 掲載の参考文献
1) 岡一雅 : 尿細管・間質の正常構造と機能, 疾患によるその破綻. 病理と臨床 39 : 103-107, 2021
Medical*Online
2) Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philaderphia, 2015, pp104-117
 
3) Tervaert TW, et al : Pathologic classification of diabetic nephropathology. J Am Soc Nephrol 21 : 556-563, 2010
 
4) Trimarchi H, et al : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 91 : 1014-1021, 2017
 
5) Loupy A, et al : The Banff 2015 Kidney Meeting Report : Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant 17 : 28-41, 2017
PubMed
P.118 掲載の参考文献
1) Mescher AL : Junqueira's Basic Histology : Text and Atlas, 13th ed., McGraw-Hill Medical, New York, 2013
 
2) 伊藤隆 : 組織学, 改訂19版, 南山堂, 2005
 
3) Kierszenbaum AL, et al : Histology and Cell Biology : An Introduction to Pathology E-book, Elsevier Health Sciences, Philadelphia, 2015
 
4) Kumar V, et al : Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-book, 9th ed., Elsevier Health Sciences, Philadelphia, 2014
 
5) Rubin R, et al. Rubin's Pathology : Clinicopathologic Foundations of Medicine, Lippincott Williams & Wilkins, Philadelphia, 2008
 
6) 上杉憲子 : 動脈硬化の病理. 日腎会誌 58 : 97-103, 2016
 
7) McCullough PA, et al : Accelerated atherosclerotic calcification and Monckeberg's sclerosis : a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 3 : 1585-1598, 2008
PubMed
P.126 掲載の参考文献
1) Mescher AL, et al : Junqueira's Basic Histology : Text and Atlas, 13th ed., McGraw-Hill Medical, New York, 2013
 
2) Kumar V, et al : Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-book, 9th ed., Elsevier Health Sciences, New York/Philadelphia, 2014
 
3) 上杉憲子 : 動脈硬化の病理. 日腎会誌 58 : 97-103, 2016
 
4) 重松秀一ほか監訳 : 腎疾患の病理アトラス-尿細管間質疾患と血管疾患のWHO分類, 東京医学社, 2005
 
5) Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7 th ed., Wolters Kluwer, Philadelphia, 2014
 
6) 両角國男ほか編 : 移植腎臨床病理アトラス : カルシニューリンインヒビターと腎, 東京医学社, 2005
 
7) Mihatsch MJ, et al : The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 49 : 356-363, 1998
PubMed
8) Naesens M, et al : Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4 : 481-508, 2009
PubMed
9) 城謙輔ほか : 薬剤性腎障害の病理. 日腎会誌 54 : 958-971, 2012
 
10) Toriu N, et al : Renal-limited thrombotic microangiopathy due to bevacizumab therapy for metastatic colorectal cancer : a case report. Case Rep in Oncol 12 : 391-400, 2019
PubMed
11) Mizuno S, et al : Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition disease. CEN Case Rep 10 : 537-542, 2021
PubMed
P.135 掲載の参考文献
1) Jennette JC, et al : 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
2) 小川弥生 : 血管炎症候群. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス改訂版, 東京医学社, 2017, pp254-260
 
3) Takahashi K, et al : Kawasaki disease : basic and pathological findings. Clin Exp Nephrol 17 : 690-693, 2013
PubMed
4) Sada KE, et al : Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16 : R101, 2014
 
5) 小川弥生 : 好酸球性多発血管炎性肉芽腫症・腎病理医の視点より. 腎と透析 86 (増刊号), 95-97, 2019
 
6) Komatsu H, et al. Clinical manifestations of Henoch-Scho nlein purpura nephritis and IgA nephropathy : comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 20 : 552-560, 2016
 
7) Ion O, et al : Kidney involvement in hypocomplementemic urticarial vasculitis syndrome : a case-based review. J Clin Med 9 : 2131, 2020
PubMed
8) Akpolat T, et al : Renal Behc et's disease : an update. Semin Arthritis Rheum 38 : 241-248, 2008
 
9) Cho SB, et al : Renal manifestations in 2007 Korean patients with Behcet's disease. Yonsei Med J 54 : 189-196, 2013
PubMed
10) 鈴木道彦ほか : MPO-ANCA 関連腎炎を呈したCogan症候群の一例. 日腎会誌 38 : 423-427, 1996
 
11) Sugimoto K, et al : Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Pediatr Rheumatol Online J 12 : 15, 2014
PubMed
P.139 掲載の参考文献
1) Racusen LC, et al : The Banff 97 working classification of renal allograft pathology. Kidney Int 55 : 713-723, 1999
PubMed
2) Roberts ISD, et al : The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556, 2009
PubMed
3) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp2-8
 
4) Tomas NM, et al : Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371 : 2277-2287, 2014
PubMed
5) Yoshioka K, et al : Type IV collagen α 5 chain : normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144 : 986-996, 1994
 
6) Loupy A, et al : The Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20 : 2318-2331, 2020
 
7) 富樫有紗 : 電顕検体の固定, 包埋. 病理と臨床 36 : 1024-1029, 2018
Medical*Online
8) 國場寛子 : 電顕検体の超薄切, 電子染色. 病理と臨床 36 : 1119-1124, 2018
Medical*Online
P.151 掲載の参考文献
1) 山中宣昭 : 腎生検に必要な各種染色法. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017, pp32-43
 
2) Joh K, et al : Proposal of podocytic infolding glomerulopathy as a new disease entity : a review of 25 cases from nation-wide research in Japan. Clin Exp Nephrol 12 : 421-431, 2008
 
3) Saito Y, et al : Mesangiolysis in diabetic glomeruli : its role in the formation of nodular lesions. Kidney Int 34 : 389-396, 1988
PubMed
4) 大石奈美ほか : 熱処理を利用した新しいPTAH染色の確立. 臨床検査学教育 12 : 76-77, 2020
 
5) D'Agati VP, Stokes MB : Focal segmental glomerulosclerosis. in Jennette JC. et al (eds.) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp207-254
 
6) 久野敏 : IgG4関連腎臓病. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017, pp305-310
 
7) Kobayashi A, et al : Granular swollen epithelial cells : a histologic and diagnostic marker for mitochondrial nephropathy. Am J Surg Pathol 34 : 262-270, 2010
PubMed
8) 益澤尚子 : ミトコンドリア異常症. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017, pp219-222
 
9) Stokes MB, et al : Light chain proximal tubulopathy : clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol 27 : 1555-1565, 2016
PubMed
10) Naesens M, et al : Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4 : 481-450, 2009
PubMed
P.161 掲載の参考文献
1) 和田隆志ほか監, 佐藤 博ほか編 : 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き, 東京医学社, 東京, 2015
 
2) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 東京, 2019
 
3) 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 東京, 2017
 
4) 特集 腎生検病理診断の実際と新たな展開. 病理と臨床 34 (12) : 1259-1336, 2016
Medical*Online
5) 特集 腎病理・尿沈渣の革新. 腎臓内科 13 (4) : 399-554, 2021
 
6) 特集 腎生検から病因と病態を読む. 腎と透析 87 (10) : 530-674, 2019
 
7) Kanzaki G, et al : Immunoglobulin deposition disease and related diseases. J Nippon Med Sch 86 : 2-9, 2019
PubMed
P.169 掲載の参考文献
1) 厚生労働科学研究費補助金 難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性腎障害に関する調査研究班編, 成田一衛 監 : 第1章 定義・構成疾患・病態生理. エビデンスに基づくネフローゼ症候群診療ガイドライン 2020, 2020, pp.1-7
 
2) 厚生労働省難治性疾患克服研究事業 進行性腎障害に関する調査研究班 難治性ネフローゼ症候群分科会 : ネフローゼ症候群診療指針. 日腎会誌 53 : 78-122, 2011
 
3) Kidney Disease. Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group : KDIGO clinical practice guideline for glomerulonephritis. Kidney Int 2 (Suppl) : 139-274, 2012
 
4) 日本小児腎臓病学会編 : 定義. 小児特発性ネフローゼ症候群診療ガイドライン 2013, 診断と治療社, 2013, p. 16
 
5) Brinkkoetter PT, et al : The role of the podocyte in albumin filtration. Nat Rev Nephrol 9 : 328-336, 2013
PubMed
6) Russo LM, et al : The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells : retrieval is disrupted in nephrotic states. Kidney Int 71 : 504-513, 2007
PubMed
7) Praga M, et al : Nephrotic proteinuria without hypoalbuminemia : clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis 17 : 330-338, 1991
PubMed
8) Chen M, et al : Normoalbuminaemia is associated with IgA nephropathy in primary glomerulopathy with nephroticrange proteinuria in Chinese patients. Nephrol Dial Transplant 26 : 1247-1252, 2011
PubMed
9) Gupta S, et al : Nephrotic syndrome : oedema formation and its treatment with diuretics. Front Physiol 9 : 1868, 2019
PubMed
10) Meyrier, A et al : Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int 94 : 861-869, 2018
PubMed
11) Vaziri ND : HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol 12 : 37-47, 2016
PubMed
12) Medjeral-Thomas N, et al : Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome. Clin J Am Soc Nephrol 9 : 478-483, 2014
PubMed
13) Zhang LJ, et al : Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome : prospective evaluation of prevalence and risk factors with CT. Radiology 273 : 897-906, 2014
PubMed
14) Barbour SJ, et al : Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 81 : 190-195, 2012
PubMed
15) Lionaki S, et al : Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 7 : 43-51, 2012
PubMed
16) Barbano B, et al : Thrombosis in nephrotic syndrome. Semin Thromb Hemost 39 : 469-476, 2013
PubMed
17) Saleem, MA : Molecular stratification of idiopathic nephrotic syndrome. Nat Rev Nephrol 15 : 750-765, 2019
PubMed
18) 丸山彰一ほか : 腎炎・ネフローゼの病態と治療. 日内会誌 108 : 535-539, 2019
 
19) (No authors listed) : Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27 : 442-449, 1985
 
20) Shiiki H, et al : Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65 : 1400-1407, 2004
PubMed
21) Shao Y-N, et al : Serum immunoglobulin E can predict minimal change disease before renal biopsy. Am J Med Sci 338 : 264-267, 2009
PubMed
22) Nakayama, K et al : Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal 22 : 114-118, 2008
PubMed
23) Ichikawa K, et al : The clinical and pathological characteristics of nephropathies in connective tissue diseases in the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 21 : 1024-1029, 2017
PubMed
P.177 掲載の参考文献
1) 白井小百合ほか : 腎生検病理診断に必要な臨床情報. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017, pp10-17
 
2) 成田一衛監 : エビデンスに基づくIgA腎症診療ガイドライン 2020, 東京医学社, 2020
 
3) 長田道夫ほか : IgA腎症. なぜパターン認識だけで腎病理は読めないのか? 医学書院, 2017, pp100-110
 
4) Andeen NK, et al : IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. Human Pathol 81 : 272-280, 2018
PubMed
5) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp185-191
 
6) Inaga S, et al : Rapid three-dimensional analysis of renal biopsy sections by low-vacuum scanning electron microscopy. Arch Histol Cytol 73 : 113-125, 2011
 
7) Haas M, et al : Consensus definitions for glomerular lesions by light and electron microscopy : recommendations from a working group of the Renal Pathology Society. Kidney Int 98 : 1120-1134, 2020
 
8) Haas M : Thin glomerular basement membrane nephropathy : incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med 130 : 699-706, 2006
PubMed
9) Hotta O, et al : Regression of IgA nephropathy : a repeat biopsy study. Am J Kidney Dis 39 : 493-502, 2002
PubMed
10) Anders HJ, et al : A pathophysiology-based approach to thediagnosis and treatment of lupus nephritis. Kidney Int 90 : 493-501, 2016
 
11) Vizjak A, et al : Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19 : 2237-2244, 2008
 
P.186 掲載の参考文献
1) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2 (Suppl) : 1-138, 2012
 
2) 三井亜希子ほか : AKIの病理組織. Modern physician 31 : 17-21, 2011
 
3) Makris K, et al : Acute kidney injury : definition, pathophysiology and clinical phenotypes. Clin Biochem Rev 37 : 85-98, 2016
PubMed
4) Farrington K, et al : Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med 70 : 221-233, 1989
PubMed
5) Haas M, et al : Etiologies and outcome of acute renal insufficiency in older adults : a renal biopsy study of 259 cases. Am J Kidney Dis 35 : 433-447, 2000
PubMed
6) Fiorentino M, et al : Renal Biopsy in 2015-from epidemiology to evidence-based indications. Am J Nephrol 43 : 1-19, 2016
PubMed
7) Kudose S, et al : Sensitivity and specificity of pathologic findings to diagnose lupus nephritis. Clin J Am Soc Nephrol 14 : 1605-1615, 2019
PubMed
8) Zaidan M, et al : Spectrum and prognosis of noninfectious renal mixed cryoglobulinemic GN. J Am Soc Nephrol 27 : 1213-1224, 2016
PubMed
10) Li C, et al : Clinicopathological study of mixed cryoglobulinemic glomerulonephritis secondary to hepatitis B virus infection. BMC Nephrol 21 : 395, 2020
PubMed
10) 小川弥生 : ANCA関連血管炎 (AAV). 日本腎病理協会/日本腎臓学会 編 : 腎生検病理アトラス, 改訂版, 東京医学社, 2017, pp263
 
11) Muriithi AK, et al : Biopsy-proven acute interstitial nephritis, 1993-2011 : a case series. Am J Kidney Dis 64 : 558-566, 2014
PubMed
P.196 掲載の参考文献
1) Dispenzieri A : POEMS syndrome : 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 94 : 812-827, 2019
PubMed
2) Leung N, et al : Monoclonal gammopathy of renal significance. N Engl J Med. 384 : 1931-1941, 2021
PubMed
3) Sethi S, et al : The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol 29 : 1810-1823, 2018
PubMed
4) Leung N, et al : Monoclonal gammopathy of renal significance : when MGUS is no longer undetermined or insignificant. Blood 120 : 4292-4295, 2012.
 
5) Leung N, et al : The evaluation of monoclonal gammopathy of renal significance : a consensus report of the international kidney and monoclonal gammopathy research group. Nat Rev Nephrol 15 : 45-59, 2019
 
6) Larsen CP, et al : Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int 88 : 867-873, 2015.
PubMed
7) Ravindran, et al : C3 glomerulopathy-associated with a monoclonal Ig is a distinct subtype. Kidney Int 94 : 178-186, 2018
 
8) Kenzaki G, et al : Monoclonal immunoglobulin deposition disease and related diseases. J Nippon Med Sch 86 : 2-9, 2019
 
9) Cornell, LD : Monoclonal immunoglobulin deposition disease. in Robert B. et al. (eds) : Diagnostic Pathology : Kidney Diseases, 3rd ed., Elsevier, Philadelphia, 2020, pp208-215.
 
10) Stokes MB, et al : Light chain proximal tubulopathy : clinical and pathologic characteristics in the odern treatment era. J Am Soc Nephrol 27 : 1555-1565, 2016
 
11) Larsen CP, et al : The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation. Mod Pathol 24 : 1462-1469, 2011
PubMed
12) Nasr SH, et al : Paraffin Immunofluorescence : A valuable ancillary technique in renal pathology. Kidney Int Rep 3 : 1260-1266, 2018
PubMed
13) Larsen CP, et al : Membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int 86 : 154-161, 2014
PubMed
P.204 掲載の参考文献
1) De Vusser K, et al. The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol 24 : 1913-1923, 2013.
PubMed
2) 両角國男ほか : 生体腎移植ドナーガイドライン. 日本臨床腎移植学会ホームページ. https://www.jscrt.jp/wp-content/themes/jscrt/pdf/guideline/guideline3.pdf
 
3) Suzuki K, et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63 : 2286-2294, 2003
PubMed
4) Loupy A, et al. The Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20 : 2318-2331, 2020
 
5) Masutani K, et al. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy. Nephrology (Carton) suppl 2 : 45-50, 2015
 
P.209 掲載の参考文献
1) Park E, et al : Familial IPEX syndrome : different glomerulopathy in two siblings. Pediatr Int 57 : e59-61, 2015
PubMed
2) Wang, Z et al : Clinicopathological characteristics of familial SLE patients with lupus nephritis. Lupus 18 : 243-248, 2009
PubMed
3) Schena FP, et al : Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 13 : 453-460, 2002
PubMed
4) Wolf MT, et al : Nephronophthisis. Pediatr Nephrol 26 : 181-194, 2011
PubMed
5) Nozu K, et al : A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23 : 158-168, 2019
PubMed
6) Savige J, et al : Thin basement membrane nephropathy. Kidney Int 64 : 1169-1178, 2003
PubMed
7) Witzgall R : Nail-patella syndrome. Pflugers Arch 469 : 927-936, 2017
PubMed
8) Colpart P, et al : Fabry nephropathy. Arch Pathol Lab Med 141 : 1127-1131, 2017
PubMed
P.219 掲載の参考文献
1) Churg J, et al : Pathology of the nephrotic syndrome in children : a report for the International Study of Kidney Disease in Children. Lancet 760 : 1299-1302, 1970
 
2) Barisoni L, et al : A proposed taxonomy for the podocytopathies : a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2 : 529-542, 2007
PubMed
3) D'Agati VD, et al : Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kidney Dis 43 : 368-82, 2004
PubMed
4) Rosenberg AZ, et al : Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 12 : 502-517, 2017
PubMed
5) Sadowski CE, et al : A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. Am Soc Nephrol 26 : 1279-1289, 2015
PubMed
6) Nagata M, et al : Focal segmental glomerulosclerosis ; why does it occur segmentally? Pflugers Arch 469 : 983-988, 2017
PubMed
7) D'Agati VD, et al. Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol 8 : 399-406, 2013
PubMed
8) 日本腎病理協会/日本腎臓学会腎病理標準化委員会編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019
 
9) Ozeki T, et al. Nephrotic syndrome with focal segmental glomerular lesions unclassified by Columbia classification ; Pathology and clinical implication. PLoS One 16 : e0244677, 2021
PubMed
P.232 掲載の参考文献
1) Berger, J et al : Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 74 : 694-695, 1968
 
2) Colvin RB, et al : Diagnostic Pathology : Kidney Diseases, 3rd ed, AMIRSYS, 2019
 
3) 成田一衛 監修, 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性腎障害に関する調査研究班 編 : エビデンスに基づくIgA腎症診療ガイドライン 2020, 東京医学社, 2020
 
4) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al : The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 76 : 546-556, 2009
 
5) D'Agati VD, et al : Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kidney Dis 43 : 368-382, 2004
PubMed
6) Soares MFS, et al : Histologic classification of IgA nephropathy : past, present, and future. Semin Nephrol 38 : 477-484, 2018
PubMed
7) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al : The Oxford classification of IgA nephropathy : rationale, clinicopathological correlations, and classification. Kidney Int 76 : 534-545, 2009
 
8) Trimarchi H, et al : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 91 : 1014-1021, 2017
 
9) 進行性腎障害に関する調査研究班IgA腎症分科会 : IgA腎症診療指針-第3版-. 日本腎臓学会誌 53 : 123-135, 2011
 
10) Heaton JM, et al : Localization of glomerular "deposits" in Henoch-Schonlein nephritis. Histopathology 1 : 93-104, 1977
PubMed
11) Counahan R, et al : Prognosis of Henoch-Schonlein nephritis in children. Br Med J 2 : 11-4, 1977
PubMed
12) Jennette JC, et al : Heptinstall's Pathology of the Kidney, 6th ed, Lippincott Williams & Wilkins, 2007
 
P.240 掲載の参考文献
1) Couser WG : Primary membranous nephropathy. Clin J Am Soc Nephrol 12 : 983-997, 2017
PubMed
2) Ronco P, et al : Pathogenesis of membranous nephropathy : recent advances and future challenges. Nat Rev Nephrol 8 : 203-213, 2012
PubMed
3) Beck LH Jr, et al : M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361 : 11-21, 2009
PubMed
4) Akiyama S, et al : Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol 19 : 653-660, 2015
 
5) Hara S, et al : Reappraisal of PLA2R1 in membranous nephropathy : immunostaining method influence and association with IgG4-dominant phenotype. Virchows Arch 467 : 87-94, 2015
PubMed
6) Tomas NM, et al : Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371 : 2277-2287, 2014
PubMed
7) Seth S, et al : Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30 : 1123-1136, 2019
 
8) Sethi S, et al : Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97 : 163-174, 2020
PubMed
9) Sethi S, et al : Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int 98 : 1253-1264, 2020
PubMed
10) Caza TN, et al : Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 100 : 171-181, 2021
PubMed
11) Sethi S, et al : Protocadherin 7-associated membranous nephropathy. J Am Soc Nephrol 32. 1249-1261, 2021
PubMed
12) Al-Rabadi LF, et al : Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy. J Am Soc Nephrol 32 : 1666-1681, 2021
PubMed
13) Caza TN, et al : Transforming growth factor beta receptor 3 (TGFBR3) -associated membranous nephropathy. Kidney 360 2 : 1275-1286, 2021
PubMed
14) Le Quintrec M, et al : Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy. Kidney Int 100 : 1240-1249, 2021
PubMed
15) Bobart SA, et al : A target antigen-based approach to the classification of membranous nephropathy. Mayo Clin Proc 96 : 577-591, 2021
 
16) Alsharhan L, et al : Membranous nephropathy : core curriculum 2021. Am J Kidney Dis 77 : 440-453, 2021
PubMed
17) Xu Z, et al : Advances in pathogenesis of idiopathic membranous nephropathy. Kidney Dis 6 : 330-345, 2020
PubMed
18) Shiiki H, et al : Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65 : 1400-1407, 2004
PubMed
19) Rovin BH, et al : Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int 100 : 753-779, 2021
PubMed
20) Logt AV, et al : Anti-PLA2R1 antibodies as prognostic biomarker in membranous nephropathy. Kidney Int Rep 6 : 1677-1686, 2021
PubMed
21) Caza TN, et al : NELL1 is a target antigen in malignancy-associated membranous nephropathy. Kidney Int 99 : 967-976, 2021
PubMed
22) Hara S, et al : Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy. Virchows Arch 474 : 735-743, 2019
 
23) Lefaucheur C, et al : Membranous nephropathy and cancer : Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70 : 1510-1517, 2006
PubMed
24) Dauvergne M, et al : Membranous nephropathy associated with immunological disorder-related liver disease : A retrospective study of 10 Cases. Medicine (Baltimore) 94 : e1243, 2015
PubMed
25) Larsen CP, et al : Membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int 2014, 86 : 154-161
 
26) Hui M, et al : C4d immunohistochemistry in membranous nephropathy. J Lab Physicians 6 : 76-79, 2014
PubMed
27) Hemminger J, et al : IgG subclass staining in routine renal biopsy material. Am J Surg Pathol 40 : 617-626, 2016
PubMed
28) Sachdeva M, et al : Phospholipase A2 receptor antibody-positive pregnancy : A case report. Am J Kidney Dis 76 : 586-589, 2020
PubMed
29) Sawamura M, et al : Membranous nephropathy with solitary polyclonal IgA deposition : a case report and literature review. Clin Nephrol Case Stud 7 : 60-65, 2019
PubMed
30) Ravindran A, et al : In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32 : 695-706, 2021
PubMed
31) Joh K, et al : Proposal of podocytic infolding glomerulopathy as a new disease entity : a review of 25 cases from nationwide research in Japan. Clin Exp Nephrol 12 : 421-431, 2008
PubMed
32) Watts AJB, et al : Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol 33 : 238-252, 2022
 
33) Xiong S, et al : Podocytic infolding in Schimke immunoosseous dysplasia with novel SMARCAL1 mutations : a case report. BMC Nephrol 21 : 170, 2020
PubMed
34) Wostmann F, et al : Case report : a peculiar glomerulopathy in a patient suffering from nephrotic syndrome. BMC Nephrol 20 : 326, 2019
 
35) Hanamura K, et al : Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol 42 : 649-658, 2011
PubMed
36) Alexander MP, et al : Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 83 : 455-462, 2013
PubMed
37) Honda K, et al : De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney. Clin Transplant 25 : 191-200, 2011
PubMed
38) Hiramatsu R, et al : Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis. Hum Pathol 50 : 187-194, 2016
PubMed
39) Nagahama K, et al : Bucillamine induces membranous glomerulonephritis. Am J Kidney Dis 39 : 706-712, 2002
PubMed
P.250 掲載の参考文献
1) Fakhouri F, et al : C3 glomerulopathy : a new classification. Nat Rev Nephrol 6 : 494-499, 2010
PubMed
2) Sethi S, et al : Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6 : 1009-1017, 2011
PubMed
3) 坪井直毅ほか : 膜性増殖性糸球体腎炎とC3腎症. 南学正臣 編 : プロフェッショナル腎臓病学, 中外医学社, 2020, pp175-182
 
4) 本田一穂 : 膜性増殖性糸球体腎炎の病理 : 過去・現在・未来 (特集 糸球体腎炎). 日腎会誌 58 : 638-647, 2016
 
5) Rovin BH, et al : Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100 : 753-779, 2021
PubMed
6) 辻隆裕ほか : 膜性増殖性糸球体腎炎. 日本腎病理協会ほか編 : 腎生検病理アトラス 改訂版, 東京医学社, 2017, pp132-138
 
7) 城謙輔ほか : ジョーシキ! 腎病理診断エッセンシャル, 南山堂, 2020, pp104-131
 
8) Haas M, et al : Consensus definitions for glomerular lesions by light and electron microscopy : recommendations from a working group of the Renal Pathology Society. Kidney Int 98 : 1120-1134, 2020
 
9) Pickering MC, et al : C3 glomerulopathy : consensus report. Kidney Int 84 : 1079-1089, 2013
PubMed
10) Larsen CP, et al : Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int 88 : 867-873, 2015
PubMed
11) Sethi S, et al : Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 366 : 1119-1131, 2012
 
12) Appel GB, et al : Membranoproliferative glomerulonephritis type II (dense deposit disease) : an update. J Am Soc Nephrol 16 : 1392-1403, 2005
PubMed
13) Smith RJH, et al : C3 glomerulopathy-understanding a rare complement-driven renal disease. Nat Rev Nephrol 15 : 129-143, 2019
PubMed
14) 日本腎病理協会ほか編 : C3腎症. 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, pp66-69
 
15) Ravindran A, et al : C3 glomerulopathy : ten years' experience at Mayo Clinic. Mayo Clin Proc 93 : 991-1008, 2018
 
16) Cornell LD : C3 Glomerulonephritis. in Colvin RB, et al (eds) : Diagnostic Pathology : Kidney Diseases, Elsevier, 2019, pp114-119
 
17) Farris AB, 3rd : Dense deposit disease. in Colvin RB, et al (eds) : Diagnostic Pathology : Kidney Diseases, Elsevier, 2019, pp108-113
 
18) Sethi S, et al : C4 dense-deposit disease. N Engl J Med 370 : 784-786, 2014
PubMed
19) Sethi S, et al : C4 glomerulopathy : a disease entity associated with C4d deposition. Am J Kidney Dis 67 : 949-953, 2016
PubMed
20) Farris AB 3rd : Membranoproliferative glomerulonephritis with immune complexes. in Colvin RB et al (eds) : Diagnostic Pathology : Kidney Diseases, Elsevier, 2019, pp120-127
 
P.252 掲載の参考文献
1) 城謙輔ほか : ジョーシキ! 腎病理診断エッセンシャル, 南山堂, 2020, pp104-116
 
2) 城謙輔 : ジョーシキ! 腎生検電顕ATLAS, 南山堂, 2016, pp177-189
 
3) Hou J, et al : Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int 85 : 450-456, 2014
 
4) Fakhouri F, et al : Practical management of C3 glomerulopathy and Ig-mediated MPGN : facts and uncertainties. Kidney Int 98 : 1135-1148, 2020
PubMed
P.256 掲載の参考文献
1) Nasr SH, et al : Proliferative glomerulonephritis with monoclonal IgG deposits : a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65 : 85-96, 2004
PubMed
2) Gumber R, et al : A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int 94 : 199-205, 2018
PubMed
3) Buxeda A, et al : Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin deposits in kidney allografts treated with anti-CD20 antibodies. Transplantation 103 : 1477-1485, 2019
 
4) Nagae H, et al : Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy. Clin Exp Nephrol 21 : 266-274, 2017
PubMed
5) Yahata M, et al : Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstrom's macroglobulinemia : case report and review of the literature. Clin Nephrol 77 : 254-260, 2012
PubMed
6) Nasr SH, et al : Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20 : 2055-2064, 2009
PubMed
7) Bhutani G, et al : Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc 90 : 587-596, 2015
PubMed
8) Said SM, et al : Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Kidney Int 94 : 159-169, 2018
PubMed
9) Sawada A, et al : Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Nephrology (Carlton) 21 (Suppl 1) : 48-52, 2016
 
10) Komatsuda A, et al : Monoclonal immunoglobulin deposition disease associated with membranous features. Nephrol Dial Transplant 23 : 3888-3894, 2008
PubMed
11) Masai R, et al : Characteristics of proliferative glomerulonephritis with monoclonal IgG deposits associated with membranoproliferative features. Clin Nephrol 72 : 46-54, 2009
PubMed
12) Xing G, et al : Proliferative glomerulonephritis with monoclonal IgG deposits in children and young adults. Pediatr Nephrol 33 : 1531-1538, 2018
 
13) Kawanishi K, et al : Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin G deposits leads to rapid graft loss after kidney transplantation : a case report. CEN Case Rep 3 : 139-144, 2014
 
14) Bridoux F, et al : Proliferative glomerulonephritis with monoclonal immunoglobulin deposits : a nephrologist perspective. Nephrol Dial Transplant 36 : 208-215, 2021
PubMed
15) Vignon M, et al : The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. Kidney Int 91 : 720-728, 2017
PubMed
16) Oe Y, et al : Proliferative glomerulonephritis with monoclonal IgM-κ deposits in chronic lymphocytic leukemia/small lymphocytic leukemia : case report and review of the literature. CEN Case Rep 2 : 222-227, 2013
 
17) Sethi S, et al : Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 5 : 770-782, 2010
PubMed
P.265 掲載の参考文献
1) KDOQI : Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 : S12-154, 2007
PubMed
2) 日本腎臓学会 : 第16章 糖尿病性腎臓病 (DKD). エビデンスに基づくCKD診療ガイドライン 2018, 2018, pp104-105
 
3) Wada T, et al : Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and allcause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18 : 613-620, 2014
PubMed
4) Ninomiya T, et al : Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20 : 1813-1821, 2009
PubMed
5) 北村博司 : 糖尿病性腎症. 日本腎病理協会ほか編 : 腎生検病理アトラス 改訂版, 東京医学社, 2017, p158
 
6) Mise K, et al : Paratubular basement membrane insulative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. PLoS One 12 : e0183190, 2017
 
7) Dai DF, et al : Interstitial eosinophilic aggregates in diabetic nephropathy : allergy or not? Nephrol Dial Transplant 30 : 1370-1376, 2015
PubMed
8) Houghton DC, et al : An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis. Mod Pathol 24 : 1480-1487, 2011
 
9) Bus P, et al : Complement activation in patients with diabetic nephropathy. Kidney Int Rep 3 : 302-313, 2017
PubMed
10) Tervaert TW, et al : Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21 : 556-563, 2010
 
11) Mise K, et al : Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant 29 : 109-118, 2014
PubMed
12) 和田隆志ほか監, 佐藤博ほか編 : 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き, 東京医学社, 2015
 
13) Hoshino J, et al : A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy. PLoS One 13 : e0190923, 2018
 
14) Li W, et al : Idiopathic nodular glomerulosclerosis : a clinicopathologic study of 15 cases. Hum Pathol 39 : 1771-1776, 2008
PubMed
15) Salvatore SP, et al : Smoking-related glomerulopathy : expanding the morphologic spectrum. Am J Nephrol 41 : 66-72, 2015
PubMed
16) Elfenbein IB, et al : Crescents in diabetic glomerulopathy. Incidence and clinical significance. Lab Invest 33 : 687-695, 1975
PubMed
17) Salvatore SP, et al : Collapsing glomerulopathy superimposed on diabetic nephropathy : insights into etiology of an underrecognized, severe pattern of glomerular injury. Nephrol Dial Transplant 29 : 392-399, 2014
PubMed
P.275 掲載の参考文献
1) Benson MD, et al : Amyloid nonmenclature 2020 : update and recommendations by the International Society of Amyloidosis (ISA) nonmenclature committee. Amyloid 27 : 217-222, 2020
 
2) Gono T, et al : AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal γ heavy chain carrying an unusal truncated D segment. Am J Kidney Dis 47 : 908-914, 2006
 
3) Von Hutten H, et al : Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol 33 : 1198-1205, 2009
PubMed
4) Larsen CP, et al : Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int 77 : 816-819, 2010
PubMed
5) 星井嘉信 : アミロイドーシスの免疫組織化学診断. 病理と臨床 34 : 481-485, 2016
Medical*Online
6) Naiki H, et al : Human amyloidosis, still intractable but becoming curable : the essential role of pathological diagnosis in the selection of type-specific therapeutics. Pathol Int 70 : 191-198, 2020
PubMed
7) 厚生労働科学研究費補助金 難治性疾患政策研究事業 アミロイドーシスに関する調査研究班 : アミロイドーシス病型診断コンサルテーションについて http://amyloidosis-research-committee.jp/consultation/
 
8) Hoshino J, et al : Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemin amyloidosis. NDT Plus 1 : 414-416, 2008
 
9) Yamazaki O, et al : Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation. Clin Exp Nephrol 13 : 522-525, 2009
 
10) Okuda Y, et al : Successful use of a humanized antiinterleukin-6 receptor antibody, Tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 54 : 2997-3000, 2006
 
11) Buxbaum JN, et al : Monoclonal immunoglobulin deposition disease : light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112 : 455-464, 1990
PubMed
P.278 掲載の参考文献
1) Benson MD, et al : Amyloid nomenclature 2020 : update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27 : 217-222, 2020
PubMed
2) Abe R, et al : Distribution of amyloidosis subtypes based on tissue biopsy site - Consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int 71 : 70-79, 2021
 
3) Yoshinaga, T et al : The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation. J Path Clin Res 2 : 72-79, 2016
 
4) Yazaki M, et al : The first pure form of Ostertag-type amyloidosis in Japan : a sporadic case of hereditary fibrinogen Aα-chain amyloidosis associated with a novel frameshift variant. Amyloid 22 : 142-144, 2015
 
5) Yoshinaga, T et al : Giant hepatomegaly with splenotesticular enlargement in a patient with apolipoprotein A-I amyloidosis : an uncommon type of amyloidosis in Japan. Intern Med 60 : 575-581, 2021
 
P.292 掲載の参考文献
1) Herrera GA, et al : Renal diseases with organized deposits : an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 134 : 512-531, 2010
PubMed
2) Leung N, et al : The evaluation of monoclonal gammopathy of renal significance : a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nature Reviews Nephrology 15 : 45-59, 2019
 
3) Nasr SH, et al : Fibrillary glomerulonephritis : a report of 66 cases from a single institution. Clin J Am Soc Nephrol 6 : 775-784, 2011
PubMed
4) Rosenstock JL, et al : Fibrillary glomerulonephritis : an update. Kidney Int Rep 4 : 917-922, 2019
PubMed
5) Andeen N, et al : Fibrillary glomerulonephritis clinicopathologic features and atypical cases from a multiinstitutional cohort. Clin J Am Soc Nephrol 14 : 1741-1750, 2019
PubMed
6) Said SH, el al : DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients. Kidney Int 98 : 498-504, 2020
 
7) Asakawa T, et al : Fibrillary Glomerulopathy with a High Level of Myeloperoxidase-ANCA : A Case Report. Case Rep Nephrol 2020 [Article ID 6343521]
 
8) Alexander MP, et al : Congophilic fibrillary glomerulonephritis : a case series. Am J Kidney Dis 72 : 325-336, 2018
PubMed
9) Nasr SH, et al : Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants. Kidney Int 99 : 410-420, 2021
PubMed
10) Nasr SH, et al : Immunotactoid glomerulopathy : clinico pathologic and proteomic study. Nephrol Dial Transplant 27 : 4137-4146, 2012
 
11) Sethi S, et al : Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol 8 : 915-921, 2013
PubMed
12) Fabrizi F, et al : Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis 61 : 623-637, 2013
PubMed
13) Matignon M, et al : Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore) 88 : 341-348, 2009
 
14) Ferri C, et al : Mixed cryoglobulinemia : demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33 : 355-374, 2004
PubMed
15) Feiner H, et al : Ultrastructure in glomerulonephritis associated with cryoglobulinemia. A report of six cases and review of the literature. Am J Pathol 88 : 145-162, 1977
 
16) Hoelbeek J, et al : Unique renal manifestation of type I cryoglobulinemia, with massive crystalloid deposits in glomerular histiocytes, podocytes, and endothelial cells. Am J Clin Pathol 145 : 282-285, 2016
PubMed
17) Hiramatsu R, et al : Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol 18 : 88-94, 2014
PubMed
18) Sethi S, et al : Cryofibrinogen-associated glomerulonephritis. Am J Kidney Dis 69 : 302-308, 2017
PubMed
19) Ibuki E, et al : Characteristic electron-microscopic features of cryofibrinogen-associated glomerulonephritis : a case report. BMC Nephrol 21 : 27, 2020
PubMed
20) Chou A, et al : Crystalglobulinemia in multiple myeloma : a rare case report of survival and renal recovery. Can J Kidney Health Dis. 2020 May 18 ; 7 : 2054358120922629
 
21) Shintani-Domoto Y, et al : Laminar crystal deposition in large vessels in a patient with crystalglobulinemia. Pathol Int 67 : 269-272, 2017
 
22) Dogan S, et al : Crystal-storing histiocytosis : report of a case, review of the literature (80 cases) and a proposed classification. Head and Neck Pathol 6 : 111-120, 2012
 
23) Gupta RK, et al : Renal crystal-storing histiocytosis involving glomeruli : a comprehensive clinicopathologic analysis. Ann Diagn Pathol 2019 Dec ; 43 : 151403
PubMed
24) Zhang T, et al : Clinicopathologic features and outcomes in fibronectin glomerulopathy : a case series of 19 patients. Front Med (Lausanne) 7 : 439, 2020
 
25) Hara M, et al : Extraglomerular vascular involvement of glomerulopathy with fibronectin deposits. Intern Med 60 : 2103-2107, 2021
PubMed
26) Uesugi N, et al : Clinicopathological and morphometrical analysis of 5 cases from 4 families of fibronectin glomerulopathy. Nihon Jinzo Gakkai Shi 41 : 49-59, 1999
PubMed
27) Castelletti F, et al : Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc Natl Acad Sci USA 105 : 2538-2543, 2008
PubMed
28) Alchi B, et al : Collagenofibrotic glomerulopathy : clinicopathologic overview of a rare glomerular disease. Am J Kidney Dis 49 : 499-506, 2007
PubMed
29) Chen X, et al : Collagen type III glomerulopathy : case report and review of the literature. Clin Nephrol 87 : 39-46, 2017
PubMed
30) Harita Y, et al : Spectrum of LMX1B mutations : from nailpatella syndrome to isolated nephropathy. Pediatr Nephrol 32 : 1845-1850, 2017
PubMed
31) Yoshioka K, et al : Glomerular localization of type III collagen in human kidney disease. Kidney Int 35 : 1203-1211, 1989
PubMed
P.304 掲載の参考文献
1) Bajema IM et al : Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis : clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93 : 789-796, 2018
PubMed
2) Petri M et al : Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64 : 2677-2686, 2012
PubMed
3) Aringer M et al : 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 71 : 1400-1412, 2019
PubMed
4) Hahn BH, McMahon MA, Wilkinson A, et al. : American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64 : 797-808, 2012
PubMed
5) 日本腎病理協会ほか編 : 腎生検病理診断取扱い規約, 第1版, 金原出版, 2019, p22
 
6) Appel GB, et al : Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 : 1499-1515, 1994
PubMed
7) Hemminger J, et al : IgG subclass staining in routine renal biopsy material. Am J Surg Pathol 40 : 617-626, 2016
PubMed
8) Wada Y, et al : Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis. Virchows Arch 479 : 997-1005
 
9) Nawata A, et al : Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis. Histopathology 72 : 1084-1092, 2018
PubMed
10) Fanouriakis A, et al : 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79 : 713-723, 2020
 
11) Chen D, et al : Lupus podocytopathy : a distinct entity of lupus nephritis. J Nephrol 31 : 629-634, 2018
PubMed
12) Hogan JJ, et al : Drug-induced glomerular disease : immunemediated injury. Clin J Am Soc Nephrol 10 : 1300-1310, 2015
PubMed
13) Rijnink EC, et al : Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome. Nephrol Dial Transplant 32 : 654-662, 2017
PubMed
14) Hisano S, et al : Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 3 : 1637-1643, 2008
PubMed
15) Mao S, et al : Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children. Int J Clin Exp Pathol 8 : 2334-2342, 2015
PubMed
16) Choung HYG, et al : Segmental membranous nephropathy. Clin Exp Nephrol 25 : 700-707, 2021
PubMed
17) Funada M, et al : Rapidly progressive glomerulonephritis after introduction of certolizumab pegol : a case report. Mod Rheumatol Case Rep 5 : 11-15, 2021
PubMed
18) Kapoor T, et al : Renal manifestations of rheumatoid arthritis. Rheum Dis Clin North Am 44 : 571-584, 2018
PubMed
19) Colvin RB, et al : Diagnostic Pathology : Kidney Diseases, 3rd ed., Elsevier, 2019, pp1139-1148
 
20) Aiyegbusi O, et al : Renal disease in primary Sjogren's syndrome. Rheumatol Ther 8 : 63-80, 2021
PubMed
21) Bienaime F, et al : Antiphospholipid syndrome and kidney disease. Kidney Int 91 : 34-44, 2017
PubMed
22) Woodworth TG, et al : Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol 12 : 678-691, 2016
PubMed
P.310 掲載の参考文献
1) Yoshizawa N, et al : Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis : characterization of the antigen and associated immune response. J Am Soc Nephrol 15 : 1785-1793, 2004
PubMed
2) Oda T, et al : Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute post-streptococcal glomerulonephritis. J Am Soc Nephrol 16 : 247-254, 2005
 
3) Suga K, et al : A case of dense deposit disease associated with a group A streptococcal infection without the involvement of C3NeF or complement factor H deficiency. Pediatr Nephrol 25 : 1547-1550, 2010
 
4) Okabe M, et al : A case of idiopathic membranoproliferative glomerulonephritis with a transient glomerular deposition of nephritis-associated plasmin receptor antigen. Clin Exp Nephrol 16 : 337-341, 2012
PubMed
5) Kikuchi Y, et al : Streptococcal origin of a case of Henoch-Schoenlein purpura nephritis. Clin Nephrol 65 : 124-128, 2006
 
6) Odaka J, et al : A case of post-pneumococcal acute glomerulonephritis with glomerular depositions of nephritis-associated plasmin receptor. CEN Case Rep 4 : 112-116, 2015
PubMed
7) 尾田高志 : 感染症と腎炎. 日本内科学会雑誌 109 : 903-909, 2020
 
8) Handa T, et al : The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy : a single-center study. Clin Exp Nephrol 22 : 1116-1127, 2018
PubMed
9) Gupta A, et al : Glomerular diseases associated with hepatitis B and C. Adv Chronic Kidney Dis 22 : 343-351, 2015
 
10) Laurinavicius A, et al : Collapsing glomerulopathy in HIV and non-HIV patients : a clinicopathological and follow-up study. Kidney Int 56 : 2203-2213, 1999
PubMed
11) Hirsch JS, et al : Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98 : 209-218, 2020
PubMed
12) 小田原幹ほか : COVID-19における腎障害の機序と病理. 腎と透析 92 : 49-53, 2022
Medical*Online
13) Su H, et al : Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98 : 219-227, 2020
PubMed
14) Larsen CP, et al : Collapsing glomerulopathy in a patient with COVID-19. Kidney Int Rep 5 : 935-939, 2020
 
15) Peleg Y, et al : Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep 5 : 940-945, 2020
PubMed
16) Kissling S, et al : Collapsing glomerulopathy in a COVID-19 patient. Kidney Int 98 : 228-239, 2020
 
17) Nasr SH, et al : COVID-19-associated collapsing glomerulopathy : an emerging entity. Kidney Int Rep 5 : 759-761, 2020
PubMed
P.321 掲載の参考文献
1) Tryggvason K, et al : Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354 : 1387-1401, 2006
PubMed
2) Pollak MR : Familial FSGS. Adv Chronic Kidney Dis 21 : 422-425, 2014
PubMed
3) De Vriiese AS, et al : Differentiating primary, genetic, and secondary FSGS in adults : a clinicopathologic approach. J Am Soc Nephrolol 29 : 759-774, 2018
 
4) Colvin RB, et al : Diagnostic Pathology : Kidney Diseases, 3rd ed., Elsevier, 2019
 
5) Heeringa SF, et al : A novel TRPC6 mutation that causes childhood FSGS. PLoS One 4 : e7771, 2009
PubMed
6) Kaplan JM, et al : Mutations in ACTN4, encoding alphaactinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24 : 251-256, 2000
 
7) Jais JP, et al : X-linked Alport syndrome : natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11 : 649-657, 2000
 
8) Nozu K, et al : A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23 : 158-168, 2019
PubMed
9) Jeanpierre C, et al : Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computaerized mutation database. Am J Hum Genet 62 : 824-833, 1998
PubMed
10) Funk SD, et al : Pathogenicity of a human laminin β2 mutation revealed in models of Alport syndrome. J Am Soc Nephrol 29 : 949-960, 2018
 
11) Jansen JJ, et al : Mutation in mitochondrial tRNA (Leu (UUR)) gene associated with progressive kidney disease. J Am Soc Nephrol 8 : 1118-1124, 1997
PubMed
12) Zarate YA, et al : Fabry's disease. Lancet 372 : 1427-1435, 2008
PubMed
13) Quinlan RJ, et al : Modeling ciliopathies : primay cilia in development and disease. Curr Top Dev Biol 84 : 249-310, 2008
 
14) Eckardt KU, et al : Autosomal dominant tubulointerstitial kidney disease : diagnosis, classification, and management-A KDIGO consensus report. Kidney Int 88 : 676-683, 2015
PubMed
15) Hildebrandt F, et al : Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 18 : 1855-1871, 2007
PubMed
16) Braun DA, et al : Ciliopathies. Cold Spring Harb Perspect Biol 9 : a028191, 2017
PubMed
17) Devuyst O, et al : Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 5 : 60, 2019
PubMed
18) Sanna-Cherchi S, et al : Genetic basis of human congenital anomalies of the kidney and urinary tract. J Clin Invest 128 : 4-15, 2018
PubMed
19) Talati AN, et al : Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT). Prenat Diagn 39 : 679-692, 2019
PubMed
20) Rodriguez MM : Congenital anomalies of the kidney and urinary tract (CAKUT). Fetal Pediatr Pathol 33 : 293-320, 2014
PubMed
P.326 掲載の参考文献
1) Brenner B, et al : Dietary protein intake and the progressive nature of kideny disease : the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307 : 652-659, 1982
 
2) Finn L, et al : The Kideny and lower urinary tract. in Husain AN et al (eds) : Stocker and Dehner's Pediatric Pathology, 4th ed., Wolters Kluwer, 2016, pp800-864
 
3) Samuel T, et al : Applicability of the glomerular size distribution coefficient in assessing human glomerular volume : the Weibel and Gomez method revisited. J Anat 210 : 578-582, 2007
 
4) 和田隆志ほか監, 佐藤 博ほか編 : 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き, 東京医学社, 2015, pp649-725
 
5) Hirano D, et al : Association between low birth weight and childhood-onset chronic kidney disease in Japan : a combined analysis of a nationwide survey for paediatric chronic kidney disease and the National Vital Statistics Report. Nephrol Dial Transplant 31 : 1895-1900, 2016
PubMed
6) Manalich R, et al : Relationship between weight at birth and the number and size of renal glomeruli in humans : a histomorphometric study. Kidney Int 58 : 770-773, 2000
PubMed
7) Ikezumi Y, et al : Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis. Am J Nephrol 38 : 149-157, 2013
PubMed
8) Deegens JKJ, et al : Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74 : 1568-1576, 2008
PubMed
9) DeMarco VG, et al : The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 10 : 364-376, 2014
PubMed
10) Lakkis JI, et al : Obesity and kidney disease. Prog Cardiovasc Dis 61 : 157-167, 2018
PubMed
11) 脇野修ほか : 腎とインスリン抵抗性. 日本腎臓学会誌 56 : 28-41, 2014
 
12) 島本和明ほか : インスリン抵抗性と高血圧. 日本内科学会雑誌 96 : 9-15, 2007
 
13) Kambham N, et al : Obesity-related glomerulopathy : an emerging epidemic. Kidney Int 59 : 1498-1509, 2001
PubMed
14) Goumenos DS, et al : Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant 24 : 3732-3738, 2009
PubMed
P.335 掲載の参考文献
1) Jennette JC, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
2) Fujimoto S, et al : Comparison of the epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50 : 1916-1920, 2011
 
3) 成田一衛 監, 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性腎障害に関する調査研究班 編 : エビデンスに基づく急速進行性腎炎症候群RPGN診療ガイドライン 2020, 東京医学社, 2020
 
4) Jayne DRW, et al : Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol 28 : 2756-2767, 2017
PubMed
5) Vizjak A, et al : Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41 : 539-549, 2003
PubMed
6) Boudhabhay I, et al : Reappraisal of renal arteritis in ANCA-associated vasculitis : clinical characteristics, pathology, and outcome. J Am Soc Nephrol 32 : 2362-2374, 2021
PubMed
7) Jennette JC, et al : Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135 : 921-930, 1989
PubMed
8) Hendricks AR, et al : Renal medullary angiitis : a case series from a single institution. Hum Pathol 44 ; 521-525, 2013
PubMed
9) Berden AE, et al : Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21 : 1628-1636, 2010
PubMed
10) Van Daalen EE, et al : Developments in the histopathological classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol 15 : 1103-1111, 2020
PubMed
11) Brix SR, et al : Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int 94 ; 1177-1188, 2018
PubMed
12) Pedchenko V, et al : Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. New Engl J Med 363 : 343-354, 2010
PubMed
13) 難病情報センター : 抗糸球体基底膜腎炎 (指定難病221). https://www.nanbyou.or.jp/entry/4379 (2022年8月閲覧)
 
14) Van Daalen EE, et al : Predicting outcome in patients with anti-GBM glomerulonephritis. Clin J Am Soc Nephrol 13 : 63-72, 2018
 
15) Fisher EG, et al : Anti-glomerular basement membrane glomerulonephritis : a morphologic study of 80 cases. Am J Clin Pathol 125 : 445-450, 2006
 
16) Yamaguchi H, et al : A case report of the anti-glomerular basement membrane glomerulonephritis with mesangial IgA deposition. CEN Case Rep 2 : 6-10, 2013
PubMed
17) McAdoo SP, et al : Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92 : 693-702, 2017
PubMed
18) Pillebout E, et al : Henoch-Schonlein purpura in adults : outcome and prognostic factors. J Am Soc Nephrol 13 : 1271-1278, 2002
PubMed
P.344 掲載の参考文献
1) Barbour T, et al : Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 27 : 2673-2685, 2012
PubMed
2) 加藤規利ほか : 非典型的溶血性尿毒症症候群 (aHUS) の診断と治療. Thrombosis Medicine 10 : 225-231, 2020
 
3) Bu F, et al : Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25 : 55-64, 2014
PubMed
4) Warwicker P, et al : Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53 : 836-844, 1998
PubMed
5) Morton JM, et al : Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract 12 : 523-530, 2016
 
6) Le Quintrec M, et al : Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant 8 : 1694-1701, 2008
PubMed
7) Borg M, et al : Renal toxicity after total body irradiation. Int J Radiat Oncol Biol Phys 54 : 1165-1173, 2002
PubMed
8) Eremina V, et al : VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358 : 1129-1136, 2008
PubMed
9) Pfister F, et al : Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy. Histopathology 73 : 990-1001, 2018
PubMed
P.346 掲載の参考文献
1) キャッスルマン病診療ガイドライン統括委員会 キャッスルマン病診療ガイドライン作成ワーキンググループ : キャッスルマン病診療ガイドライン 令和2年度初版, 2020 https://castleman.jp (2022年1月閲覧)
 
2) Mizuno H. et al : The clinical and histopathological feature of renal manifestation of TAFRO syndrome. Kidney Int Rep 5 : 1172-1179, 2020
PubMed
3) Furutera N, et al : Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab. CEN Case Rep 10 : 35-41, 2021
PubMed
P.355 掲載の参考文献
1) Denic A, et al : Glomerular volume and glomerulosclerosis at different depths within the human kidney. J Am Soc Nephrol 30 : 1471-1480, 2019
 
2) Hommos MS, et al : Structural and functional changes in human kidneys with healthy aging. J Am Soc Nephrol 28 : 2838-2844, 2017
PubMed
3) O'Sullivan ED, et al : Renal aging : causes and consequences. J Am Soc Nephrol 28 : 407-420, 2017
PubMed
4) Rule AD, et al : The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152 : 561-567, 2010
PubMed
5) 和田隆志ほか監, 佐藤博ほか編 : 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き, 東京医学社, 2015
 
6) Kanetsuna Y. et al : Central fibrous areas : changes in glomerular vascular pole lesions associated with age and disease. Int Urol Nephrol 54, September 2022. doi : 10.1007/s11255-022-03126-3
 
7) Kubo M, et al : Risk factors for renal glomerular and vascular changes in an autopsy-based population survey : the Hisayama study. Kidney Int 63 : 1508-1515, 2003
 
8) Hill GS, et al : Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 69 : 823-831, 2006
PubMed
9) Hill GS, et al : Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation. Kidney Int 63 : 1027-1036, 2003
PubMed
10) loupy A, et al : The Banff 2015 Kidney Meeting Report : current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant 17 : 28-41, 2017
PubMed
11) Furuichi K, et al : Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transplant 33 : 138-148, 2018
PubMed
12) Shima N, et al : Characteristic renal histology of a 81-year-old patient with a 30-year history of diabetes mellitus : a case report. CEN Case Rep 9 : 338-343, 2020
PubMed
13) Min W, et al : Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Arch A Pathol Anat Histopathol 423 : 201-207, 1993
 
14) Sawada A, et al : Glomerular neovascularization in non-diabetic renal allograft is associated with calcineurin inhibitor toxicity. Nephron 144 (Suppl 1) : 37-42, 2020
 
15) Timmermans SAMEG, et al : Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. Kidney Int 91 : 1420-1425, 2017
PubMed
16) Thind G, et al : Malignant hypertension as a rare case of thrombotic microangiopathy. BMJ Case Rep 2017 : bcr2017220457, 2017
PubMed
17) Lip GYH, et al : Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs? Am J Hypertens 13 : 934-939, 2000
 
18) Kitiyakara C, et al : Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9 : 133-142, 1998
PubMed
19) Fukuda K. et al : A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension. CEN Case Rep 2 : 68-75, 2013
 
P.362 掲載の参考文献
1) Brodsky SV, et al : Acute and chronic tubulointerstitial nephritis. in Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2014, pp1111-1165
 
2) Muriithi AK, et al : Biopsy-proven acute interstitial nephritis, 1993-2011 : a case series. Am J Kidney Dis 64 : 558-566, 2014
PubMed
3) Alexander MP, et al : Renal extramedullary hematopoiesis : interstitial and glomerular pathology. Mod Pathol 28 : 1574-1583, 2015
PubMed
4) Valeyre D, et al : Sarcoidosis. Lancet 383 : 1155-1167, 2014
PubMed
5) Naderi S, et al : Renal involvement in sarcoidosis : histologic findings and clinical course. Nephrology @ Point of Care 5 : 1-8, 2019
 
6) Mahevas M, et al : Renal sarcoidosis : clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 88 : 98-106, 2009
PubMed
7) Tsukada H, et al : Bilateral nephromegaly due to isolated renal sarcoidosis. Clin Exp Nephrol 21 : 169-170, 2017
PubMed
8) Conz PA, et al : TINU syndrome associated with reduced complement levels. Nephron 89 : 340-341, 2001
PubMed
9) Li C, et al : Tubulointerstitial nephritis with uveitis in Chinese adults. Clin J Am Soc Nephrol 9 : 21-28, 2014
PubMed
10) Legendre M, et al : Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults : a national retrospective strobe-compliant study. Medicine (Baltimore) 95 : e3964, 2016
PubMed
11) Mandeville JT, et al : The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46 : 195-208, 2001
PubMed
12) 小林賛光, 山口裕 : 髄放線障害. 腎と透析. 87 : 171-177, 2019
Medical*Online
13) Fujimaru T, et al : Genetic background and clinicopathologic features of adult-onset nephronophthisis. Kidney Int Rep 6 : 1346-1354, 2021
PubMed
14) Morimoto N, et al : A novel LMX1B variant identified in a patient presenting with severe renal involvement and thin glomerular basement membrane. Nephron 145 : 776-782, 2021
 
P.367 掲載の参考文献
1) Hamano H, et al : High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 : 732-738, 2001
PubMed
2) Umehara H, et al : A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details. Mod Rheumatol 22 : 1-14, 2012
PubMed
3) Saeki T, et al : Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 78 : 1016-1023, 2010
PubMed
4) Kawano M, et al : Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 15 : 615-626, 2011.
PubMed
5) 川野充弘ほか : IgG4 関連腎臓病診療指針. 日腎会誌 53 : 1062-1073, 2011
 
6) Saeki T, et al : Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version. Clin Exp Nephrol 25 : 99-109, 2021
PubMed
7) 佐伯敬子 : IgG4関連腎臓病診断基準 2020 (IgG4関連腎臓病診断基準 2011 改訂版). 日腎会誌 63 : 187-197, 2021
 
8) Evans RDR, et al : Clinical manifestations and long-term outcomes of IgG4-related kidney and retroperitoneal involvement in a United Kingdom IgG4-related disease cohort. Kidney Int Rep 4 : 48-58, 2018
 
9) Zeng Q, et al : Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients. Sci Re 11 : 10397, 2021
 
10) Brito-Zeron P, et al : Therapeutic approach to IgG4-related disease : a systematic review. Medicine (Baltimore) 95 : e4002, 2016
PubMed
11) Masaki Y, et al : A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease. Mod Rheumatol 27 : 849-854, 2017
PubMed
12) Carruthers MN, et al : Rituximab for IgG4-related disease : a prospective, open-label trial. Ann Rheum Dis 74 : 1171-1177, 2015
PubMed
13) Backhus J, et al : A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab. J Clin Med 10 : 1329, 2021
PubMed
14) Della-Torre E, et al : Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease : an observational prospective open-label cohort study. Eur J Intern Med 84 : 63-67, 2021
PubMed
15) Raissian Y, et al : Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22 : 1343-1352, 2011
PubMed
P.370 掲載の参考文献
1) Takahashi N, et al : Tubulointerstitial nephritis with IgM-positive plasma cells. J Am Soc Nephrol 28 : 3688-3698, 2017
PubMed
2) Minato M, et al : Glucocorticoid-dependent tubulointerstitial nephritis with IgM-positive plasma cells presenting with intracellular crystalline inclusions within the rough endoplasmic reticulum. Intern Med 60 : 3129-3136, 2021
PubMed
P.378 掲載の参考文献
1) 日本造血細胞移植データセンター/日本造血細胞移植学会 : 日本における造血細胞移植. 2020年度 全国調査報告書 http://www.jdchct.or.jp/data/report/2020/?msclkid=ffdc144bc4fe11eca3fae586650ad7af
 
2) Parikh CR, et al : Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67 : 1999-2005, 2005
PubMed
3) Renaghan AD, et al : Acute kidney injury and CKD associated with hematopoietic stem cell transplantation. Clin J Am Soc Nephrol 15 : 289-297, 2020
PubMed
4) Abboud I, et al : Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation : monitoring and management guidelines. Semin Hematol 49 : 73-82, 2012
PubMed
5) Hingorani S : Renal complications of hematopoietic-cell transplantation. N Engl J Med 374 : 2256-2267, 2016
PubMed
6) Homma CI, et al : Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation. Bone Marrow Transplant 35 : 929-930, 2005
PubMed
7) Kusumi E, et al : Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients : possible involvement of graft-versus-host disease. Int J Hematol 87 : 225-230, 2008
PubMed
8) Higo S, et al : Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation. PLoS One 9 : e115399, 2014
PubMed
9) Schmid PM, et al : Acute renal graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Cell Transplant 26 : 1428-1440, 2017
 
10) Brukamp K, et al : Nephrotic syndrome after hematopoietic cell transplantation : do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 1 : 685-694, 2006
PubMed
11) Troxell ML, et al : Renal pathology associated with hematopoietic stem cell transplantation. Adv Anat Pathol 21 : 330-340, 2014
PubMed
12) Girsberger M, et al : Kidney pathology after hematologic cell transplantation - a single-center observation study of indication biopsies and autopsies. Biol Blood Marrow Transplant 24 : 571-580, 2018
 
13) El-Seisi S, et al : Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 9 : 683-688, 2003
PubMed
14) Brinkerhoff BT, et al : Renal pathology in hematopoietic cell transplant recipients : a contemporary biopsy, nephrectomy, and autopsy series. Mod Pathol 29 : 637-652, 2016
PubMed
15) Remuzzi G, et al : Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 52 : S70-74, 1995
PubMed
16) Ruggenenti P, et al : Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43 : 706-711, 1993
PubMed
17) Kim JY, et al : Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Korean Med Sci 10 : 352-359, 1995
PubMed
18) Langenberg C, et al : The histopathology of septic acute kidney injury : a systematic review. Crit Care 12 : R38, 2008
PubMed
19) Lopes da Silva R : Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther 4 : 51-59, 2011
PubMed
20) Bayer G, et al : Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol 14 : 557-566, 2019
PubMed
21) Naesens M, et al : Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4 : 481-508, 2009
PubMed
22) Liptak P, et al : Primer : histopathology of calcineurininhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2 : 398-404, 2006
PubMed
23) Lusco MA, et al : AJKD atlas of renal pathology : calcineurin inhibitor nephrotoxicity. Am J Kidney Dis 69 : e21-e22, 2017
PubMed
24) Zoltan G, et al : Thrombotic microangiopathies. in Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, Philadelphia, 2015, pp 739-814
 
25) Mii A, et al : Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Pathol Int 61 : 518-527, 2011
PubMed
P.387 掲載の参考文献
1) 厚生省特定疾患進行性腎障害調査研究班ほか : 厚生省特定疾患進行性腎障害調査研究班研究業績集 平成3年度, pp71-74
 
2) Loh AHL, et al : Drug-induced kidney disease-pathology and current concepts. Ann Acad Med Singap 38 : 240-250, 2009
PubMed
3) 城謙輔ほか : 薬剤性腎障害の病理. 日腎会誌 54, 958-971, 2012
 
4) van den Berg JG, et al : Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66 : 1901-1906, 2004
PubMed
5) Arnaud L, et al : Drug-induced systemic lupus : revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database. Ann Rheum Dis 78 : 504-508, 2019
PubMed
6) Siddiqui W, et al : Acute kidney injury due to sucrose-containing intravenous immunoglobulins. Saudi J Kidney Dis Transpl 30 : 732-737, 2019
PubMed
7) Ansari FA, et al : A rare case of acute kidney injury due to levofloxacin-induced crystal nephropathy. Indian J Nephrol 29 : 424-426, 2019
PubMed
P.389 掲載の参考文献
1) Wanchoo R, et al : Adverse renal effects of immune checkpoint inhibitors : a narrative review. Am N Nephrol 45 : 160-169, 2017
 
2) Cortazar FB, et al : Clinical features and outcomes of immune checkpoint inhibitor-associated AKI : a multicenter study. J Am Soc Nephrol 31 : 435-446, 2020
 
3) Perazella MA, et al : Immune checkpoint inhibitor nephrotoxicity : what do we know and what should we do? Kidney Int 97 : 62-74, 2020
PubMed
4) 原重雄 : 免疫チェックポイント阻害薬による腎障害. 病理と臨床 39 : 161-169, 2021
Medical*Online
P.391 掲載の参考文献
1) Muller-Hocker J, et al : Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease : case report and review of the literature. Hum Pathol 34 : 285-289, 2003
PubMed
2) Manabe S, et al : Lupus nephritis and hydroxychloroquine-associated zebra bodies : not just in Fabry disease. Kidney Med 3 : 442-446, 2021
 
3) Pons-Estel GJ, et al : Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis : LXV, data from a multiethnic US cohort. Arthritis Rheum 61 : 830-839, 2009
PubMed
P.396 掲載の参考文献
1) Kitai Y, et al : Onco-nephrology : current concepts and future perspectives. Jpn J Clin Oncol 45 : 617-628, 2015
PubMed
2) Niscola P, et al : Hematologists and nephrologists working together : moving forward with a new integrated care model for blood-related malignancies? Blood Res 52 : 218-219, 2017
PubMed
3) 冨田茂樹ほか : M蛋白関連腎症の最新の進歩. 病理と臨床 34 : 1296-1303, 2016
Medical*Online
4) Wu AJ, et al : Metastases to the kidney : a clinicopathological study of 43 cases with an emphasis on deceptive features. Histopathology 66 : 587-597, 2015
 
5) Richmond J, et al : Renal lesions associated with malignant lymphomas. Am J Med 32 : 184-207, 1962
PubMed
6) Pothen L, et al : Nephrotic syndrome without kidney injury revealing intravascular large B cell lymphoma. BMJ Case Rep 12 : e229359, 2019
 
7) Taneja A, et al : Primary renal lymphoma : A population-based analysis using the SEER program (1973-2015). Eur J Haematol 104 : 390-399, 2020
PubMed
8) Matsue K, et al : Diagnosis of intravascular large B cell lymphoma : novel insights into clinicopathological features from 42 patients at a single institution over 20 years. Br J Haematol 187 : 328-336, 2019
 
9) Oba R, et al : A case of intravascular large B-cell lymphoma with renal involvement presenting with elevated serum ANCA titers. CEN Case Rep 10 : 59-63. 2021
 
10) Hunter S, et al : Diagnosis of renal lymphoma by percutaneous image guided biopsy : experience with 11 cases. J Urol 176 : 1952-1956, 2006
 
11) Silverman SG, et al : Impact of positive findings at imageguided biopsy of lymphoma on patient care : evaluation of clinical history, needle size, and pathologic findings on biopsy performance. Radiology 190 : 759-764, 1994
PubMed
12) Desclaux A, et al : Renal intravascular large B-cell lymphoma : a case report and review of the literature. Intern Med 56 : 827-833, 2017
 
13) 好川貴久ほか : 高齢者の腎障害と慢性炎症-inflammaging-. Geriatric Medicine 58 : 897-901, 2021
 
14) Segerer S, et al : B cells and tertiary lymphoid organs in renal inflammation. Kidney Int 73 : 533-537, 2008
PubMed
P.412 掲載の参考文献
1) Loupy A, Haas M, et al : The Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell - and antibody - mediated rejection. Am J Transplant 20 : 2318-2331, 2020
 
2) Jennette JC, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed., Wolters Kluwer, 2015, pp13-15
 
3) Nankivell BJ, et al : Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection? Am J Transplant 19 : 132-144, 2019
 
4) Lefaucheur C, et al : T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. Am J Transplant 18 : 377-390, 2018
 
5) Mannon RB, et al : Inflammation in areas of tubular atrophy in kidney allograft biopsies : a potent predictor of allograft failure. Am J Transplant 10 : 2066-2073, 2010
PubMed
6) Nankivell BJ, et al : The causes, significance and consequences of inflammatory fibrosis in kidney transplantation : The Banff i-IFTA lesion. Am J Transplant 18 : 364-376, 2018
PubMed
7) Roufosse C, et al : A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation 102 : 1795-1814, 2018
 
8) Nakagawa K, et al : Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification : Surveillance by 1-year protocol biopsies for kidney transplantation. Am J Transplant 21 : 174-185, 2021
PubMed
9) Kung VL, et al : Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy. Kidney Int 100 : 391-400, 2021
PubMed
10) 日本移植学会 臓器移植抗体陽性診療ガイドライン策定委員会 : 臓器移植抗体陽性診療ガイドライン 2018年版, メディカルレビュー社, 大阪, 2018
 
11) Wiebe C, et al : Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 12 : 1157-1167, 2012
PubMed
12) Aubert O, et al : Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients. J Am Soc Nephrol 28 : 1912-1923, 2017
 
13) Kozakowski N, et al : The diffuse extent of peritubular capillaritis in renal allograft rejection is an independent risk factor for graft loss. Kidney Int 88 : 332-340, 2015
PubMed
14) Batal I, et al : A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 10 : 2442-2452, 2010
PubMed
P.418 掲載の参考文献
1) Bhattacharjee S, et al : Entry, infection, replication, and egress of human polyomaviruses : an update. Can J Microbiol 63 : 193-211, 2017
PubMed
2) Purighalla R, et al : BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 26 : 671-673, 1995
 
3) Masutani K, et al : Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia. Transplantation 94 : 43-49, 2012
PubMed
4) Hirsch HH, et al : BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33 : e13528, 2019
PubMed
5) Hariharan S : BK virus nephritis after renal transplantation. Kidney Int 69 : 655-662, 2006
PubMed
6) Nickeleit V, et al : The 2018 Banff Working Group classification of definitive polyomavirus nephropathy : a multicenter validation study in the modern era. Am J Transplant 21 : 669-680, 2021
 
7) Haas M, et al : Banff 2013 Meeting Report : inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14 : 272-283, 2014
PubMed
8) Nickeleit V, et al : The Banff Working Group classification of definitive polyomavirus nephropathy : morphologic definitions and clinical correlations. J Am Soc Nephrol 29 : 680-693, 2018
 
9) Loupy A, et al : Banff 2019 Kidney Meeting Report (I) : Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20 : 2318-2331, 2020
 
10) Hofland CA, et al : Hemorrhagic adnovirus cystitis after renal transplantation. Transplant Proc 36 : 3025-3027, 2004
 
11) 花岡希ほか : アデノウイルス・単純ヘルペスウイルス性尿道炎診断における迅速免疫クロマトキットの有用性に関する検討 (第2報) -尿沈渣検体ではアデノウイルスを高感度・高特異度に検出可能-. 日本性感染症学会雑誌 30 : 45-49, 2019
 
12) Florescu MC, et al : What do we know about adenovirus in renal transplantation? Nephrol Dial Transplant 28 : 2003-2010, 2013
PubMed
13) Allen U, et al : Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients. Am J Transplant 9 (Suppl 4) : S87-S 96, 2009
 
14) Caillard S, et al : Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults : report of 230 cases from the French Registry. Am J Transplant 6 : 2735-2742, 2006
PubMed
15) Quinlan SC, et al : Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 86 : 206-209, 2011
PubMed
16) Morton M, et al : Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients. Transplantation 95 : 470-478, 2013
PubMed
17) Swerdlow SH, et al (eds) : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th ed., IARC, Lyon, 2017
 

書評

最近チェックした商品履歴

Loading...